部落格

• 
  Avidity’s RNA Therapy Ushers in New Genetically Targeted Drugs for DMD

  發佈者 uttej 1 day, 19 hours 前   public

  The North America Duchenne Muscular Dystrophy (DMD) Treatment Market is set for significant growth, expanding from USD 2.06 billion in 2024 to USD 8.84 billion by 2033, at an impressive compound ...

  comment 0

  thumb_upLike

  0 0 0 0 0 0 0

  share 0